PL
PL · PL · PL-100406325
Kanjinti
ATC L01FD01
Last synced from URPL (Poland) on
Identification
ManufacturerAmgen Europe B.V.
CountryPL (PL)
ATC codeL01FD01
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 1
- gtin08715131016982
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Proszek do sporządzania koncentratu do przygotowania roztworu do infuzji",
"source": "urpl",
"strength": "150 mg",
"packaging": "08715131016982 ¦ Rpz ¦ EU/1/18/1281/001 ¦ 128439\n1 fiol. 20 ml",
"substance": "Trastuzumabum 150 mg",
"common_name": "Trastuzumabum",
"pl_product_id": "100406325",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code L01FD01.
- FIDazublysCurateq Biologics s.r.o.
- ISDazublysCurateq Biologics s.r.o.
- PLDazublysCuraTeQ Biologics s.r.o.
- FIDazublysCurateq Biologics s.r.o.
- DKDazublysCurateq Biologics s.r.o.
- CZDAZUBLYSCuraTeQ Biologics s.r.o., Praha
- BEDazublys 150 mgCuraTeQ Biologics
- NLDazublys 150 mg poeder voor concentraat voor oplossing voor infusie.Curateq Biologics s.r.o.
Access this data programmatically
Query Kanjinti and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.